AAVLife Company
AAVLife is a privately held company dedicated to advancing gene therapy for rare diseases.
Technology:
Cardiovascular Disorders
Industry:
Gene Therapy
Headquarters:
Paris, Ile-de-France, France
Founded Date:
2014
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Register and Claim Ownership